Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Colloidal Pectin Quadruple Therapy for H. Pylori
NCT04660123Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of colloidal bismuth pectin in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started Dec 2020; status: completed.
02
Drugs
colloidal bismuth pectin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04660123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04660123.